vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $35.3M, roughly 1.8× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -70.9%, a 114.8% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs 8.1%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 17.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
CTKB vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $35.3M |
| Net Profit | $-44.1M | $15.5M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 55.8% |
| Net Margin | -70.9% | 43.9% |
| Revenue YoY | 8.1% | 24.2% |
| Net Profit YoY | -557.1% | 34.5% |
| EPS (diluted) | — | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $35.3M | ||
| Q3 25 | $52.3M | $32.8M | ||
| Q2 25 | $45.6M | $34.4M | ||
| Q1 25 | $41.5M | $29.4M | ||
| Q4 24 | $57.5M | $28.4M | ||
| Q3 24 | $51.5M | $27.7M | ||
| Q2 24 | $46.6M | $25.5M | ||
| Q1 24 | $44.9M | $25.6M |
| Q4 25 | $-44.1M | $15.5M | ||
| Q3 25 | $-5.5M | $14.4M | ||
| Q2 25 | $-5.6M | $16.5M | ||
| Q1 25 | $-11.4M | $11.6M | ||
| Q4 24 | $9.6M | $11.5M | ||
| Q3 24 | $941.0K | $10.9M | ||
| Q2 24 | $-10.4M | $9.5M | ||
| Q1 24 | $-6.2M | $9.6M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 55.8% | ||
| Q3 25 | -17.6% | 57.5% | ||
| Q2 25 | -23.3% | 62.6% | ||
| Q1 25 | -36.1% | 52.6% | ||
| Q4 24 | 5.2% | 51.0% | ||
| Q3 24 | -8.2% | 52.7% | ||
| Q2 24 | -18.3% | 49.3% | ||
| Q1 24 | -23.9% | 50.0% |
| Q4 25 | -70.9% | 43.9% | ||
| Q3 25 | -10.5% | 43.8% | ||
| Q2 25 | -12.2% | 48.0% | ||
| Q1 25 | -27.5% | 39.5% | ||
| Q4 24 | 16.8% | 40.5% | ||
| Q3 24 | 1.8% | 39.4% | ||
| Q2 24 | -22.4% | 37.1% | ||
| Q1 24 | -13.8% | 37.5% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | — | $1.41 | ||
| Q2 25 | — | $1.61 | ||
| Q1 25 | — | $1.13 | ||
| Q4 24 | — | $1.13 | ||
| Q3 24 | — | $1.07 | ||
| Q2 24 | — | $0.92 | ||
| Q1 24 | — | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $345.6M |
| Total Assets | $461.5M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $345.6M | ||
| Q3 25 | $378.6M | $334.0M | ||
| Q2 25 | $377.6M | $319.8M | ||
| Q1 25 | $379.6M | $306.1M | ||
| Q4 24 | $395.7M | $295.6M | ||
| Q3 24 | $385.5M | $284.3M | ||
| Q2 24 | $389.1M | $273.4M | ||
| Q1 24 | $392.6M | $266.8M |
| Q4 25 | $461.5M | $3.0B | ||
| Q3 25 | $494.9M | $2.9B | ||
| Q2 25 | $493.3M | $2.9B | ||
| Q1 25 | $482.6M | $2.8B | ||
| Q4 24 | $499.5M | $2.7B | ||
| Q3 24 | $491.2M | $2.6B | ||
| Q2 24 | $483.7M | $2.6B | ||
| Q1 24 | $492.1M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $44.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $44.3M |
| FCF MarginFCF / Revenue | -2.9% | 125.7% |
| Capex IntensityCapex / Revenue | 1.6% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $44.9M | ||
| Q3 25 | $-3.9M | $45.5M | ||
| Q2 25 | $108.0K | $-25.3M | ||
| Q1 25 | $-125.0K | $17.9M | ||
| Q4 24 | $2.0M | $48.0M | ||
| Q3 24 | $13.2M | $17.7M | ||
| Q2 24 | $6.2M | $-8.4M | ||
| Q1 24 | $4.0M | $15.8M |
| Q4 25 | $-1.8M | $44.3M | ||
| Q3 25 | $-4.6M | $45.3M | ||
| Q2 25 | $-1.5M | $-25.5M | ||
| Q1 25 | $-974.0K | $17.6M | ||
| Q4 24 | $1.1M | $47.3M | ||
| Q3 24 | $12.2M | $17.5M | ||
| Q2 24 | $5.2M | $-8.6M | ||
| Q1 24 | $3.4M | $15.7M |
| Q4 25 | -2.9% | 125.7% | ||
| Q3 25 | -8.7% | 138.1% | ||
| Q2 25 | -3.2% | -74.2% | ||
| Q1 25 | -2.3% | 59.9% | ||
| Q4 24 | 1.9% | 166.5% | ||
| Q3 24 | 23.7% | 63.3% | ||
| Q2 24 | 11.0% | -33.7% | ||
| Q1 24 | 7.6% | 61.4% |
| Q4 25 | 1.6% | 1.6% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 3.5% | 0.5% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 1.6% | 2.4% | ||
| Q3 24 | 2.0% | 0.5% | ||
| Q2 24 | 2.3% | 0.5% | ||
| Q1 24 | 1.3% | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | 0.21× | 4.17× | ||
| Q3 24 | 14.05× | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
UNTY
Segment breakdown not available.
